Two Days, Two Deals: AbbVie To Partner (Again) With Galapagos In Cystic Fibrosis
This article was originally published in The Pink Sheet Daily
Executive Summary
AbbVie’s busy week continued when it unveiled a collaboration with Galapagos in cystic fibrosis Sept. 24, a day after it announced an inflammatory disease tie-up with Ablynx. AbbVie and Galapagos already are partnered under a 2012 deal in rheumatoid arthritis and Crohn’s disease.